Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea

Bibliographic Details
Title: Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea
Authors: Pierre Allard, Nareen Alhaj, Stephan Lobitz, Holger Cario, Andreas Jarisch, Regine Grosse, Lena Oevermann, Dani Hakimeh, Laura Tagliaferri, Elisabeth Kohne, Annette Kopp-Schneider, Andreas E. Kulozik, Joachim B. Kunz
Source: Haematologica, Vol 107, Iss 7 (2021)
Publisher Information: Ferrata Storti Foundation, 2021.
Publication Year: 2021
Collection: LCC:Diseases of the blood and blood-forming organs
Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5
More Details: The course of sickle cell disease (SCD) is modified by polymorphisms boosting fetal hemoglobin (HbF) synthesis. However, it has remained an open question how these polymorphisms affect patients who are treated with the HbF-inducing drug hydroxyurea/ hydroxycarbamide. The German SCD registry offers the opportunity to answer this question, because >90% of patients are treated according to national guidelines recommending the use of hydroxyurea in all patients above 2 years of age. We analyzed the modifying effect of HbF-related genetic polymorphisms in 417 patients with homozygous SCD >2 years old who received hydroxyurea. HbF levels were correlated with higher total hemoglobin levels, lower rates of hemolysis, a lower frequency of painful crises and of red blood cell transfusions. The minor alleles of the polymorphisms in the γ-globin promoter (rs7482144), BCL11A (rs1427407) and HMIP (rs66650371) were strongly associated with increased HbF levels. However, these associations did not translate into lower frequencies of vaso-occlusive events which did not differ between patients either carrying or not carrying the HMIP and BCL11A polymorphisms. Patients on hydroxyurea carrying the γ-globin promoter polymorphism demonstrated substantially higher hemoglobin levels (P
Document Type: article
File Description: electronic resource
Language: English
ISSN: 0390-6078
1592-8721
Relation: https://haematologica.org/article/view/10440; https://doaj.org/toc/0390-6078; https://doaj.org/toc/1592-8721
DOI: 10.3324/haematol.2021.278952
Access URL: https://doaj.org/article/6917040d732d4b14a269d5e926b9d34b
Accession Number: edsdoj.6917040d732d4b14a269d5e926b9d34b
Database: Directory of Open Access Journals
More Details
ISSN:03906078
15928721
DOI:10.3324/haematol.2021.278952
Published in:Haematologica
Language:English